Filing Details

Accession Number:
0000950170-24-131170
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-26 18:13:10
Reporting Period:
2024-11-22
Accepted Time:
2024-11-26 18:13:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817838 Douglas Joseph Lyon C/O Corcept Therapeutics Incorporated
101 Redwood Shores Parkway
Redwood City CA 94065
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-11-22 1,411 $56.72 8,494 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Includes 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.